The program was created to address a gap in Medicare coverage and recognizes that obesity is a chronic disease that often requires medical treatment beyond diet and exercise alone
Quebec Class Action On November 6, 2023, Siskinds Desmeules filed an application for authorization to institute a class action before the Superior Court of Quebec on behalf a proposed class of Canadians who suffered injuries arising from the consumption of GLP-1 drugs manufactured by Novo Nordisk, which was subsequently amended on February 6, 2026
The lawsuit names both Novo Nordisk Inc., the New Jersey-based subsidiary that markets the drug in the United States, and Novo Nordisk A/S, the Danish parent company
Outterson K, Powers JH, Daniel GW, McClellan MB
Surgery And Other Procedures Withholding of food and fluids during surgical or other procedures may increase the risk for volume depletion, hypotension and renal impairment